FDA Accelerates Clinical Trials with Real-Time Data, Pfizer Extends Vyndamax Patent Until 2031
The FDA is piloting real-time clinical trial data reviews with AstraZeneca and Amgen, while Pfizer settles patent disputes to extend Vyndamax protecti...
The FDA is piloting real-time clinical trial data reviews with AstraZeneca and Amgen, while Pfizer settles patent disputes to extend Vyndamax protecti...
Astellas is reentering clinical trials for its next-generation XLMTM gene therapy following patient deaths. Eli Lilly acquires Ajax Therapeutics for u...